Estrogen regulation of angiotensin-converting enzyme mRNA

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 323-328

  Gallagher, Patricia E ^a   Li, Ping ^a   Lenhart, John R ^a   Chappell, Mark C ^a   Brosnihan, K Bridget ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme; Estrogen; Gene regulation; Hormone replacement; Reverse transcriptase polymerase chain reaction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; ESTROGEN THERAPY; GENETIC REGULATION; HEART PROTECTION; HORMONE SUBSTITUTION; MESSENGER RNA SYNTHESIS; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

EID: 0032899714     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.323     Document Type: Article

References (51)

1. Castelli WP. Cardiovascular disease in women. Am J Obstet Gynecol. 1988;158:1553-1560.
2. Wentz AC. Women's health issues. In: Wentz AC, ed. Advances in Internal Medicine. St Louis, Mo: Mosby-Year Book, Inc; 1994:1-30.
3. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
4. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
5. PEPI Trial Working Group. Effects of estrogen or estrogen/progestin regimes on heart disease risk factors in postmenopausal woman. JAMA. 1995;273:199-208.
6. Farmer JA, Gotto AM Jr. Current and future therapeutic approaches to hyperlipidemia. Adv Pharmacol. 1996;35:79-114.
7. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88: 1995-2002.
8. Riedel M, Raffenbeul W, Lichtlen P. Ovarian sex steroids and atherosclerosis. Clin Invest. 1993;71:406-412.
9. Keaney JF Jr, Shwaery GT, Xu A, Nicolosi RJ, Loscalzo J, Foxall TL, Vita JA. 17β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 1994;89:2251-2259.
10. Wagner JD, Schwenke DC, Zhang L, Applebaum-Bowden D, Bagdade JD, Adams MR. Effects of short-term hormone replacement therapies on low-density lipoprotein metabolism in cynomolgus monkeys. Arterioscler Thromb Vasc Biol. 1997;17:1128-1134.
11. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activity of three angiotensin processing enzymes: angiotensin convening enzyme, prolyl endopeptidase, and neutral endopeptidase. Life Sci. 1993;52:1461-1480.
12. Corvol P, Michaud A, Soubrier F, Williams T. Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. J Hypertens. 1995;13(suppl 3):S3-S10.
13. Villard E, Soubrier F. Molecular biology and genetics of the angiotensin-I-converting enzyme: potential implications in cardiovascular diseases. Cardiovasc Res. 1996;32:999-1007.
14. Tallant EA, Ferrario CM. Biology of angiotensin II receptor inhibition with a focus on losartan: a new drug for the treatment of hypertension. Exp Opin Invest Drugs. 1996;5:1201-1214.
15. Hecker M, Bara AT, Bauerachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol. 1994;481:407-414.
16. Hecker M, Dambcher T, Busse R. Role of endothelium-derived bradykinin in the control of vascular tone. Cardiovasc Pharmacol. 1992;20: S55-S61.
17. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996;27: 523-528.
18. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997;29:394-400.
19. Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension. 1998;31: 362-367.
20. Brosnihan KB, Weddle D, Anthony MS, Heise C, Li P, Ferrario CM. Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys. J Hypertens. 1997;15:719-726.
21. Brosnihan KB, Li P, Ganten D, Ferrario CM. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am J Physiol. 1991;213(Regulatory Integrate Comp Physiol.): R1908-R1915.
22. Goetz RM, Morano I, Calovini T, Studer R, Holtz J. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun. 1994;205:905-910.
23. Lou Y, Robinson BG, Morris BJ. Renin messenger RNA, detected by polymerase chain reaction, can be switched on in rat atrium. J Hypertens. 1993;11:237-243.
24. Bernstein KE, Martin BM, Bernstein EA, Linton J, Striker L, Striker G. The isolation of angiotensin-converting enzyme cDNA. J Biol Chem. 1988;263:11021-11024.
25. Roy SN, Kusari J, Soffer RL, Lai CY, Sen GC. Isolation of cDNA clones of rabbit angiotensin converting enzyme: identification of two distinct mRNAs for the pulmonary and the testicular isozymes. Biochem Biophys Res Commun. 1988;155:678-684.
26. Shirasawa T, Sakamoto K, Akashi T, Takahashi H, Kawashima A. Nucleotide sequence of rat elongation factor-1 alpha cDNA. Nucl Acids Res. 1992;20:909.
27. Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol. 1995;48:601-609.
28. Lowry OH, Rosebrough MJ, Fair AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem. 1951;193:265-275.
29. Butcher RL, Collins WE, Fugo NW. Plasma concentrations of LH, FSH, prolactin, progesterone and estradiol-17β throughout the 4-day estrous cycle of the rat. Endocrinology. 1974;94:1704-1708.
30. O'Connell MB. Pharmacokinetic and pharmacologic variation between different estrogen products. J Clin Pharmacol. 1995;35:18S-24S.
31. Williams JK, Anthony MS, Honore EK, Herrington DM, Morgan TM, Register TC, Clarkson TB. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol. 1995;15:827-836.
32. Seltzer A, Pinto EB, Viglione PN, Correa FMA, Libertun C, Tsutsumi K, Steele MK, Saavedra JM. Estrogens regulate angiotensin-converting enzyme and angiotensin receptors in female rat anterior pituitary. Neuroendocrinology. 1992;55:460-467.
33. Esther CR, Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KE. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest. 1996;74:953-965.
34. Li J, Hu H-Y, Zhao Y-N. Serum angiotensin-converting enzyme activity in pregnancy-induced hypertension. Gynecol Obstel Invest. 1992;33: 138-141.
35. Rassmussen AB, Pedersen EB, Romer FK, Johannesen P, Kristensen S, Lauritsen JG, Wohlert M. Influence of normotensive pregnancy and pre-eclampsia on angiotensin-converting enzyme. Acta Obstet Gynecol Scand. 1983;62:341-344.
36. Schunkert H, Danser AHJ, Hense HW, Derkx FHM, Kurzinger S, Riegger GAJ. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation. 1997;95: 39-45.
37. Dasarathy Y, Lanzillo JJ, Fanburg BL. Stimulation of bovine pulmonary artery endothelial cell ACE by dexamethasone: involvement of steroid receptors. Am J Physiol. 1992;263:L645-L649.
38. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol. 1994;9:619-626.
39. Gaub M, Bellard M, Scheuer I, Chambon P, Sassone-Corsi PS. Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex. Cell. 1990;63:1267-1276.
40. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ, Scanian TS. Differential ligand activation of estrogen receptors ERa and ERb at AP1 sites. Science. 1997;277:1508-1510.
41. Uht RM, Anderson CM, Webb P, Kushner PJ. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology 1997;138:2900-2908.
42. Goraya TY, Kassler SP, Kumar RS, Douglas J, Sen GC. Identification of positive and negative transcriptional regulatory elements of the rabbit angiotensin-converting enzyme gene. Nucl Acids Res. 1994;22: 1194-1201.
43. Howard TR, Balogh R, Overbeek P, Bernstein KE. Sperm-specific expression of angiotensin-converting enzyme (ACE) is mediated by a 91-base-pair promoter containing a CRE-like element. Mol Cell Biol. 1993;13:18-27.
44. Shai S-Y, Lanford KG, Martin BM, Bernstein KE. Genomic DNA 5′ to the mouse and human angiotensin-converting enzyme gene contains two distinct regions of conserved sequence. Biochem Biophys Res Commun. 1990;167:1128-1133.
45. Zhou Y, Sun Z, Means AR, Sassone-Corsi P, Bernstein KE. cAMP-response element modulator is a positive regulator of testis angiotensin converting enzyme transcription. Proc Natl Acad Sci U S A. 1996;93: 12262-12266.
46. Nasjletti A, Masson GMC. Studies on angiotensinogen formation in a liver perfusion system. Circ Res. 1972;3(suppl II):II-187-II-202.
47. Tewksbury DA. Angiotensinogen: biochemistry and molecular biology. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press; 1990: 1197-1216.
48. Glorioso N, Atlas SA, Laragh JH, Jewelewicz R, Sealey JE. Prorenin in high concentrations in human ovarian follicular fluid. Science. 1986;233: 1422-1424.
49. Howard RB, Pucell AG, Bumpus FM, Husain A. Rat ovarian renin: characterization and changes during the estrous cycle. Endocrinology. 1988;123:2331-2340.
50. Rubattu S, Quimby FW, Sealey JE. Tissue renin and prorenin increase in female cats during the reproductive cycle without commensurate changes in plasma, amniotic or ovarian follicular fluid. J Hypertens. 1991;9: 525-535.
51. Chen Y, Naftilan AJ, Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension. 1992;19:456-463.